Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI.

Renato D Lopes,Pedro G M de Barros E Silva,Lucas Petri Damiani,Renato Hideo Nakagawa Santos,John H Alexander,Christopher B Granger,Otavio Berwanger

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION（2020）

引用 8|浏览53

暂无评分

摘要

This study uses SECURE-PCI trial data to compare the effects of periprocedural loading doses of atorvastatin vs placebo on major adverse cardiac events (MACE) 12 months after randomization in patients with acute coronary syndrome (ACS) and planned invasive management.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要